Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cannabis Genetics Institute is a cannabis genetics, breeding, and education company focused on applying genomics and molecular breeding tools to cannabis. The organization states that it works to preserve and reinvigorate the cannabis gene pool by archiving heirloom and landrace genetics, reintroducing male and female breeding lines, and offering certified cannabinoid- and terpene-specific seed profiles. CGI also positions itself as an open, collaborative research initiative and has described work with technical partners to map the cannabis genome and identify gene sets associated with desirable plant traits. In addition to seeds and genetics, the company provides educational content and consulting related to cultivation, breeding, and cannabis science. Its business appears to be centered on commercial cannabis genetics rather than development of regulated human therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cannabis Genetics Institute.